Keyphrases
Pathological Complete Response
100%
Cisplatin
100%
Celecoxib
100%
Advanced Esophageal Cancer
100%
Fluorouracil
100%
Twice Daily
50%
Overall Survival
50%
Chemoradiation
50%
Pneumonia
25%
Response Rate
25%
Disease Progression
25%
Diarrhea
25%
Cell Proliferation
25%
Chemotherapy
25%
Potentiation
25%
Phase II Study
25%
Maintenance Therapy
25%
Pulmonary Embolism
25%
Complete Response Rate
25%
Esophageal Cancer
25%
Esophagectomy
25%
Postoperative Complications
25%
Progressive Disease
25%
Cyclooxygenase-2 Inhibitors
25%
5-fluorouracil (5-FU)
25%
Oncology
25%
Preoperative Chemoradiation
25%
Nausea-vomiting
25%
Cyclooxygenase-2
25%
Celebrex
25%
Esophagitis
25%
Dehydration
25%
Enteral Feeding
25%
Cyclooxygenase-2 Expression
25%
Granulocytopenia
25%
Stomatitis
25%
Potentially Resectable
25%
Pharmacology, Toxicology and Pharmaceutical Science
Esophagus Cancer
100%
Cisplatin
100%
Celecoxib
100%
Fluorouracil
100%
Chemoradiation Therapy
60%
Cyclooxygenase 2
60%
Overall Survival
40%
Diarrhea
20%
Nausea
20%
Chemotherapy
20%
Disease Exacerbation
20%
Postoperative Complication
20%
Preclinical Study
20%
Lung Embolism
20%
Esophagitis
20%
Granulocytopenia
20%
Stomatitis
20%
Diseases
20%